home / stock / sprc / sprc articles


SPRC Articles, SciSparc Ltd.

Stock Information

Company Name: SciSparc Ltd.
Stock Symbol: SPRC
Market: NASDAQ

Menu

SPRC SPRC Quote SPRC Short SPRC News SPRC Articles SPRC Message Board
Get SPRC Alerts

News, Short Squeeze, Breakout and More Instantly...

Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session | Benzinga

Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial res...

Why Macatawa Bank Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of Macatawa Bank Corporation (NASDAQ: MCBC) rose sharply in today’s pre-market trading after Wintrust Financial Corporation (NASDAQ: ...

Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial resul...

SciSparc To Acquire AutoMax, A Strategic Leap Towards Industry Diversification | Benzinga

Specialty clinical-stage pharmaceutical company SciSparc Ltd. (NASDAQ:SPRC) has entered into a merger agreement with AutoMax Motors Ltd., a vehicl...

SciSparc to Acquire AutoMax | Benzinga

TEL AVIV, Israel, April 11, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a specialty clinical...

Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of Rallybio Corporation (NASDAQ: RLYB) rose sharply in today’s pre-market trading after the company announced a collaboration with Jo...

SciSparc Granted Another Patent, Strengthening its Core Technology in Canada | Benzinga

TEL AVIV, Israel, March 18, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceu...

Autism CBD Trial Enrolls Children: This Israeli Co. Is Making Headway In New Treatments | Benzinga

SciSparc Ltd. (NASDAQ:SPRC) announced on Friday that it has enrolled the first patient in the company's clinical trial assessing the efficacy ...

SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe | Benzinga

The Company's most recent patent further solidifies its position, complementing existing grants in the U.S., Japan, Australia and other key ju...

SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds | Benzinga

TEL AVIV, Israel, Feb. 27, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a specialty clinical-...

Next 10